0 Comentários
0 Compartilhamentos
487 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Feed de Notícias
- EXPLORAR
-
Páginas
-
Blogs
-
Courses
-
Movies
-
Faça Login para curtir, compartilhar e comentar!
-
Improved Diagnostics and Drug Development Drive the Tuberculous Lymphadenitis Treatment Market"Latest Insights on Executive Summary Tuberculous Lymphadenitis Treatment Market Share and Size The global tuberculous lymphadenitis treatment market size was valued at USD 327.56 billion in 2024 and is projected to reach USD 638.51 billion by 2032, with a CAGR of 8.74 % during the forecast period of 2025 to 2032. This Tuberculous Lymphadenitis Treatment Market research report...0 Comentários 0 Compartilhamentos 199 Visualizações 0 Anterior
-
Will the Sulfonylureas Market Sustain Its Role in Diabetes Treatment Amid New Drug Innovations?"Executive Summary: Sulfonylureas Market Size and Share by Application & Industry Global Sulfonylureas Market size was valued at USD 7.25 billion in 2024 and is projected to reach USD 9.32 billion by 2032, with a CAGR of 3.19% during the forecast period of 2025 to 2032. The leading Sulfonylureas Market analysis report is a careful investigation of current scenario of...0 Comentários 0 Compartilhamentos 16 Visualizações 0 Anterior
-
Amitriptyline Market: Projected to Hit $1.01 Billion by 2032Introspective Market Research (IMR) today released its comprehensive report on the Global Amitriptyline Market. According to the analysis, the market was valued at USD 609.2 million in 2023 and is projected to reach USD 1,011.9 million by 2032, growing at a compound annual growth rate (CAGR) of 5.8% from 2024 to 2032. This growth is largely underpinned by the expanding burden of depression and...0 Comentários 0 Compartilhamentos 264 Visualizações 0 Anterior
-
ANTIPSYCHOTIC DRUGS MARKET: Global Value Set to Double, Reaching $33.91 Billion by 2032Introspective Market Research (IMR) today published a new report on the Global Antipsychotic Drugs Market, forecasting it to grow from USD 17.48 billion in 2023 to USD 33.91 billion by 2032, at a compound annual growth rate (CAGR) of 7.63% over the 2024–2032 period. This expansion is largely driven by increasing global incidence of psychiatric disorders such as schizophrenia and bipolar...0 Comentários 0 Compartilhamentos 223 Visualizações 0 Anterior
-
Onychomycosis Treatment Market - Share Analysis (2024–2032)Introspective Market Research (IMR) announces the publication of its latest in-depth analysis of the Global Onychomycosis Treatment Market. Onychomycosis, a common fungal infection affecting fingernails and toenails, is demanding increasingly sophisticated and rapid treatment modalities. The market, which was valued at USD 3.5 Billion in 2023, is projected to grow to USD 5.2 Billion by 2032,...0 Comentários 0 Compartilhamentos 16 Visualizações 0 Anterior
-
Osteoarthritis Drugs MarketIntrospective Market Research (IMR) today unveiled a critical new report detailing the accelerated evolution of the Global Osteoarthritis (OA) Drugs Market. The market, valued at USD 4.70 Billion in 2023, is forecast to more than double, reaching USD 10.38 Billion by 2032, demonstrating a high-velocity Compound Annual Growth Rate (CAGR) of 9.2% during the 2024–2032 forecast period. This...0 Comentários 0 Compartilhamentos 41 Visualizações 0 Anterior
-
Respiratory Tract Infection Treatment Market - Share Analysis (2024–2032)Introspective Market Research (IMR) has released a critical analysis of the Global Respiratory Tract Infection (RTI) Treatment Market, highlighting its rapid expansion fueled by persistent global health challenges. RTIs, including pneumonia, bronchitis, and sinusitis, remain a leading cause of morbidity and mortality worldwide. The market, which was valued at USD 40.20 Billion in 2023, is...0 Comentários 0 Compartilhamentos 17 Visualizações 0 Anterior
-
The Autoimmune Gastrointestinal Dysmotility Market Uncovering Breakthroughs Behind a Silent DisorderExecutive Summary Autoimmune Gastrointestinal Dysmotility Market Size and Share Forecast CAGR Value The global autoimmune gastrointestinal dysmotility market size was valued at USD 39.45 billion in 2024 and is expected to reach USD 155.47 billion by 2032, at a CAGR of 18.70% during the forecast period Complex market insights are represented in a simpler version in the world class...0 Comentários 0 Compartilhamentos 436 Visualizações 0 Anterior
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek